Redemption Date Announced for Warrants
Monday, May 6, 2024 is Last and Final Day to Exercise Warrants.Once Redeemed, the Warrants Will Cease to Exist and Have No Value. AUSTIN, Texas, April 15, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA)
GlobeNewswireApr 15 09:20 ET
Cassava Sciences' Alzheimer's Treatment Shows Promise: A Strong Buy Recommendation
TipRanksMar 25 10:55 ET
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials. The DSMB Recommended Both Phase 3 Trials Continue as
GlobeNewswireMar 25 09:13 ET
Express News | HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $124 Price Target
Moomoo 24/7Mar 5 06:43 ET
Cassava Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/05/2024 447.46% HC Wainwright & Co. → $124 Reiterates Buy → Buy 08/08/2023 447.46% HC Wainwright & Co.
BenzingaMar 5 06:41 ET
Cassava Sciences Announces Virtual Presentation at the AD/PD 2024 International Conference
AUSTIN, Texas, March 04, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company focused on Alzheimer's disease, today announced plans to present a virtual oral
GlobeNewswireMar 4 09:15 ET
Cassava Sciences: Q4 Earnings Insights
Cassava Sciences (NASDAQ:SAVA) reported its Q4 earnings results on Wednesday, February 28, 2024 at 09:14 AM.Here's what investors need to know about the announcement.EarningsCassava Sciences beat esti
BenzingaFeb 28 16:00 ET
Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), Repare Therapeutics (RPTX)
TipRanksFeb 28 14:50 ET
Cassava Sciences Inc (SAVA) Reports Full-Year 2023 Financial Results
Yahoo FinanceFeb 28 09:52 ET
Express News | Cassava Sciences Q4 EPS $(0.50) Beats $(0.52) Estimate
Moomoo 24/7Feb 28 09:18 ET
Cassava Sciences 4Q Loss/Shr 50c >SAVA
Cassava Sciences 4Q Loss/Shr 50c >SAVA
Dow JonesFeb 28 09:14 ET
Cassava Sciences Announces Key Development With Press Release
TipRanksFeb 8 04:19 ET
Why Alzheimers-Drug Developer Cassava Sciences Stock Is Trending
Cassava Sciences, Inc. (NASDAQ:SAVA) shares are trading higher Wednesday after the company reported top-line results of a two-year clinical safety study of simufilam, an investigational oral drug for
BenzingaFeb 7 11:15 ET
Simufilam Shows Stable Scores in Mild Alzheimer's Study
InvestingFeb 7 09:26 ET
Express News | Cassava Sciences Reports Top-Line Results Of Two-Year Clinical Safety Study Of Simufilam, Investigational Oral Drug For Treatment Of Alzheimer's Disease
Moomoo 24/7Feb 7 09:18 ET
No Decline in Cognition Scores in Patients With Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
ADAS-Cog Scores Were Stable in a Group of Patients with Mild Alzheimer's Who Received Drug Candidate Simufilam Continuously, Baseline to Month 24.Mild Alzheimer's Patients Who Received Simufilam Non-C
GlobeNewswireFeb 7 09:08 ET
Cassava Sciences, Inc.'s (NASDAQ:SAVA) 7.1% Loss Last Week Hit Both Individual Investors Who Own 59% as Well as Institutions
Key Insights The considerable ownership by retail investors in Cassava Sciences indicates that they collectively have a greater say in management and business strategy A total of 25 investors have a
Simply Wall StFeb 6 05:29 ET
Cassava Sciences, Inc. (NASDAQ:SAVA) Most Popular Amongst Retail Investors Who Own 59% of the Shares, Institutions Hold 31%
Yahoo FinanceFeb 5 05:33 ET
(SAVA) - Analyzing Cassava Sciences's Short Interest
Cassava Sciences's (NYSE:SAVA) short percent of float has fallen 3.99% since its last report. The company recently reported that it has 13.33 million shares sold short, which is 33.49% of all regular
BenzingaJan 29 10:15 ET
Will the bear be hit again? Many US stocks that have been seriously shorted have risen strongly
Some US consumer stocks, which have been severely shorted, rose on Monday.
Zhitong FinanceJan 23 03:01 ET
No Data
No Data